APO Research
Talk to an analyst

APO RESEARCH · REPORT

Passive Immunizing Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Passive Immunizing Drugs Industry Growth and Trends Forecast to 2032

27 December 2025112 pages

Choose your research edition.

Industry ResearchPassive Immunizing Drugs Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Passive Immunizing Drugs Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Passive Immunizing Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Passive Immunizing Drugs Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Passive Immunizing Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Passive Immunizing Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Passive Immunizing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Passive Immunizing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Passive Immunizing Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Passive Immunizing Drugs include Xingmeng Biopharmaceuticals (Suzhou), Wuhan Institute of Biological Products, Sichuan Yuanda Shuyang Pharmaceutical, Shanxi Kangbao Biological Product, Sharon Bio-Medicine, Hualan Biological Engineering, North China Pharmaceutical, Sinopharm Group and Zydus Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Passive Immunizing Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Passive Immunizing Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Passive Immunizing Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Passive Immunizing Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Passive Immunizing Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Passive Immunizing Drugs Market by Company

Xingmeng Biopharmaceuticals (Suzhou)

Wuhan Institute of Biological Products

Sichuan Yuanda Shuyang Pharmaceutical

Shanxi Kangbao Biological Product

Sharon Bio-Medicine

Hualan Biological Engineering

North China Pharmaceutical

Sinopharm Group

Zydus Lifesciences

Serum Institute of India

Sanofi Pasteur

Kedrion Biopharma

Kamada

Haffkine Bio-Pharmaceutical

Grifols

Bharat Biotech

Passive Immunizing Drugs Segment by Type

Rabies Immunoglobulin

Rabies Virus Monoclonal Antibody

Anti-rabies Serum

Passive Immunizing Drugs Segment by Application

Category II Exposure

Category III Exposure

Passive Immunizing Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Passive Immunizing Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Passive Immunizing Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Passive Immunizing Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Passive Immunizing Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Passive Immunizing Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Rabies Immunoglobulin Table 2. Major Company of Rabies Virus Monoclonal Antibody Table 3. Major Company of Anti-rabies Serum Table 4. Global Passive Immunizing Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Passive Immunizing Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Passive Immunizing Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Passive Immunizing Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Passive Immunizing Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Passive Immunizing Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Passive Immunizing Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Passive Immunizing Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Passive Immunizing Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Passive Immunizing Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Passive Immunizing Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Passive Immunizing Drugs Industry Trends Table 26. Passive Immunizing Drugs Industry Drivers Table 27. Passive Immunizing Drugs Industry Opportunities and Challenges Table 28. Passive Immunizing Drugs Industry Restraints Table 29. Global Passive Immunizing Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Passive Immunizing Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Passive Immunizing Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Passive Immunizing Drugs Sales Share by Company (2021-2026) Table 33. Global Passive Immunizing Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Passive Immunizing Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Passive Immunizing Drugs Major Company Production Sites and Headquarters Table 36. Global Passive Immunizing Drugs Company, Product Type & Application Table 37. Global Passive Immunizing Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Passive Immunizing Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Passive Immunizing Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Passive Immunizing Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Passive Immunizing Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Passive Immunizing Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Passive Immunizing Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Passive Immunizing Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Passive Immunizing Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Passive Immunizing Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Passive Immunizing Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Passive Immunizing Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Passive Immunizing Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Passive Immunizing Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Passive Immunizing Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Passive Immunizing Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Passive Immunizing Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Passive Immunizing Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Passive Immunizing Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Passive Immunizing Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Passive Immunizing Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Passive Immunizing Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Passive Immunizing Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Passive Immunizing Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Xingmeng Biopharmaceuticals (Suzhou) Company Information Table 73. Xingmeng Biopharmaceuticals (Suzhou) Business Overview Table 74. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Product Portfolio Table 76. Xingmeng Biopharmaceuticals (Suzhou) Recent Development Table 77. Wuhan Institute of Biological Products Company Information Table 78. Wuhan Institute of Biological Products Business Overview Table 79. Wuhan Institute of Biological Products Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Wuhan Institute of Biological Products Passive Immunizing Drugs Product Portfolio Table 81. Wuhan Institute of Biological Products Recent Development Table 82. Sichuan Yuanda Shuyang Pharmaceutical Company Information Table 83. Sichuan Yuanda Shuyang Pharmaceutical Business Overview Table 84. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 86. Sichuan Yuanda Shuyang Pharmaceutical Recent Development Table 87. Shanxi Kangbao Biological Product Company Information Table 88. Shanxi Kangbao Biological Product Business Overview Table 89. Shanxi Kangbao Biological Product Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shanxi Kangbao Biological Product Passive Immunizing Drugs Product Portfolio Table 91. Shanxi Kangbao Biological Product Recent Development Table 92. Sharon Bio-Medicine Company Information Table 93. Sharon Bio-Medicine Business Overview Table 94. Sharon Bio-Medicine Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sharon Bio-Medicine Passive Immunizing Drugs Product Portfolio Table 96. Sharon Bio-Medicine Recent Development Table 97. Hualan Biological Engineering Company Information Table 98. Hualan Biological Engineering Business Overview Table 99. Hualan Biological Engineering Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Hualan Biological Engineering Passive Immunizing Drugs Product Portfolio Table 101. Hualan Biological Engineering Recent Development Table 102. North China Pharmaceutical Company Information Table 103. North China Pharmaceutical Business Overview Table 104. North China Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. North China Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 106. North China Pharmaceutical Recent Development Table 107. Sinopharm Group Company Information Table 108. Sinopharm Group Business Overview Table 109. Sinopharm Group Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Sinopharm Group Passive Immunizing Drugs Product Portfolio Table 111. Sinopharm Group Recent Development Table 112. Zydus Lifesciences Company Information Table 113. Zydus Lifesciences Business Overview Table 114. Zydus Lifesciences Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Zydus Lifesciences Passive Immunizing Drugs Product Portfolio Table 116. Zydus Lifesciences Recent Development Table 117. Serum Institute of India Company Information Table 118. Serum Institute of India Business Overview Table 119. Serum Institute of India Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Serum Institute of India Passive Immunizing Drugs Product Portfolio Table 121. Serum Institute of India Recent Development Table 122. Sanofi Pasteur Company Information Table 123. Sanofi Pasteur Business Overview Table 124. Sanofi Pasteur Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sanofi Pasteur Passive Immunizing Drugs Product Portfolio Table 126. Sanofi Pasteur Recent Development Table 127. Kedrion Biopharma Company Information Table 128. Kedrion Biopharma Business Overview Table 129. Kedrion Biopharma Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Kedrion Biopharma Passive Immunizing Drugs Product Portfolio Table 131. Kedrion Biopharma Recent Development Table 132. Kamada Company Information Table 133. Kamada Business Overview Table 134. Kamada Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Kamada Passive Immunizing Drugs Product Portfolio Table 136. Kamada Recent Development Table 137. Haffkine Bio-Pharmaceutical Company Information Table 138. Haffkine Bio-Pharmaceutical Business Overview Table 139. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Product Portfolio Table 141. Haffkine Bio-Pharmaceutical Recent Development Table 142. Grifols Company Information Table 143. Grifols Business Overview Table 144. Grifols Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Grifols Passive Immunizing Drugs Product Portfolio Table 146. Grifols Recent Development Table 147. Bharat Biotech Company Information Table 148. Bharat Biotech Business Overview Table 149. Bharat Biotech Passive Immunizing Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Bharat Biotech Passive Immunizing Drugs Product Portfolio Table 151. Bharat Biotech Recent Development Table 152. North America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. North America Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 154. North America Passive Immunizing Drugs Sales Market Share by Country (2021-2026) Table 155. North America Passive Immunizing Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 156. North America Passive Immunizing Drugs Sales Market Share Forecast by Country (2027-2032) Table 157. North America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. North America Passive Immunizing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 159. North America Passive Immunizing Drugs Market Share by Country (2021-2026) Table 160. North America Passive Immunizing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. North America Passive Immunizing Drugs Market Share Forecast by Country (2027-2032) Table 162. Europe Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Europe Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 164. Europe Passive Immunizing Drugs Sales Market Share by Country (2021-2026) Table 165. Europe Passive Immunizing Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 166. Europe Passive Immunizing Drugs Sales Market Share Forecast by Country (2027-2032) Table 167. Europe Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Europe Passive Immunizing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 169. Europe Passive Immunizing Drugs Market Share by Country (2021-2026) Table 170. Europe Passive Immunizing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Europe Passive Immunizing Drugs Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 174. Asia-Pacific Passive Immunizing Drugs Sales Market Share by Country (2021-2026) Table 175. Asia-Pacific Passive Immunizing Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 176. Asia-Pacific Passive Immunizing Drugs Sales Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Passive Immunizing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 179. Asia-Pacific Passive Immunizing Drugs Market Share by Country (2021-2026) Table 180. Asia-Pacific Passive Immunizing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Asia-Pacific Passive Immunizing Drugs Market Share Forecast by Country (2027-2032) Table 182. Latin America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Latin America Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 184. Latin America Passive Immunizing Drugs Sales Market Share by Country (2021-2026) Table 185. Latin America Passive Immunizing Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 186. Latin America Passive Immunizing Drugs Sales Market Share Forecast by Country (2027-2032) Table 187. Latin America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Latin America Passive Immunizing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 189. Latin America Passive Immunizing Drugs Market Share by Country (2021-2026) Table 190. Latin America Passive Immunizing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Latin America Passive Immunizing Drugs Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Passive Immunizing Drugs Sales by Country (2021-2026) & (K Units) Table 194. Middle East and Africa Passive Immunizing Drugs Sales Market Share by Country (2021-2026) Table 195. Middle East and Africa Passive Immunizing Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 196. Middle East and Africa Passive Immunizing Drugs Sales Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Passive Immunizing Drugs Market Size by Country (2021-2026) & (US$ Million) Table 199. Middle East and Africa Passive Immunizing Drugs Market Share by Country (2021-2026) Table 200. Middle East and Africa Passive Immunizing Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Middle East and Africa Passive Immunizing Drugs Market Share Forecast by Country (2027-2032) Table 202. Key Raw Materials Table 203. Raw Materials Key Suppliers Table 204. Passive Immunizing Drugs Distributors List Table 205. Passive Immunizing Drugs Customers List Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Passive Immunizing Drugs Image Figure 2. Global Passive Immunizing Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Passive Immunizing Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Passive Immunizing Drugs Sales (2021-2032) & (K Units) Figure 5. Rabies Immunoglobulin Image Figure 6. Global Rabies Immunoglobulin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rabies Virus Monoclonal Antibody Image Figure 8. Global Rabies Virus Monoclonal Antibody Sales YoY Growth (2021-2032) & (K Units) Figure 9. Anti-rabies Serum Image Figure 10. Global Anti-rabies Serum Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Passive Immunizing Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Passive Immunizing Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Passive Immunizing Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Passive Immunizing Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Passive Immunizing Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Passive Immunizing Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Passive Immunizing Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Passive Immunizing Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Passive Immunizing Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Passive Immunizing Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Passive Immunizing Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Passive Immunizing Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Passive Immunizing Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Category II Exposure Image Figure 26. Global Category II Exposure Sales YoY Growth (2021-2032) & (K Units) Figure 27. Category III Exposure Image Figure 28. Global Category III Exposure Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Passive Immunizing Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Passive Immunizing Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Passive Immunizing Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Passive Immunizing Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Passive Immunizing Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Passive Immunizing Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Passive Immunizing Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Passive Immunizing Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Passive Immunizing Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Passive Immunizing Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Passive Immunizing Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Passive Immunizing Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Passive Immunizing Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Passive Immunizing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Passive Immunizing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Passive Immunizing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Passive Immunizing Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Passive Immunizing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Passive Immunizing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Passive Immunizing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Passive Immunizing Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Passive Immunizing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Passive Immunizing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Passive Immunizing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Passive Immunizing Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Passive Immunizing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Passive Immunizing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Passive Immunizing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Passive Immunizing Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Passive Immunizing Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Passive Immunizing Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Passive Immunizing Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Passive Immunizing Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Passive Immunizing Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Rabies Immunoglobulin
  • Rabies Virus Monoclonal Antibody
  • Anti-rabies Serum
Applications
  • Category II Exposure
  • Category III Exposure
Companies covered
  • Xingmeng Biopharmaceuticals (Suzhou)
  • Wuhan Institute of Biological Products
  • Sichuan Yuanda Shuyang Pharmaceutical
  • Shanxi Kangbao Biological Product
  • Sharon Bio-Medicine
  • Hualan Biological Engineering
  • North China Pharmaceutical
  • Sinopharm Group
  • Zydus Lifesciences
  • Serum Institute of India
  • Sanofi Pasteur
  • Kedrion Biopharma
  • Kamada
  • Haffkine Bio-Pharmaceutical
  • Grifols
  • Bharat Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Passive Immunizing Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Passive Immunizing Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Passive Immunizing Drugs Market by Type
  6. 1.3.1 Rabies Immunoglobulin
  7. 1.3.2 Rabies Virus Monoclonal Antibody
  8. 1.3.3 Anti-rabies Serum
  9. 1.4 Global Passive Immunizing Drugs Market Size by Type
  10. 1.4.1 Global Passive Immunizing Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Passive Immunizing Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Passive Immunizing Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Passive Immunizing Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Passive Immunizing Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Passive Immunizing Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Passive Immunizing Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Passive Immunizing Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Passive Immunizing Drugs Industry Trends
  2. 2.2 Passive Immunizing Drugs Industry Drivers
  3. 2.3 Passive Immunizing Drugs Industry Opportunities and Challenges
  4. 2.4 Passive Immunizing Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Passive Immunizing Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Passive Immunizing Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Passive Immunizing Drugs Price (2021-2026)
  4. 3.4 Global Passive Immunizing Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Passive Immunizing Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Passive Immunizing Drugs Company, Product Type & Application
  7. 3.7 Global Passive Immunizing Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Passive Immunizing Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Passive Immunizing Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Passive Immunizing Drugs Tier 1, Tier 2, and Tier 3
4 Passive Immunizing Drugs Regional Status and Outlook
  1. 4.1 Global Passive Immunizing Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Passive Immunizing Drugs Historic Market Size by Region
  3. 4.2.1 Global Passive Immunizing Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Passive Immunizing Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Passive Immunizing Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Passive Immunizing Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Passive Immunizing Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Passive Immunizing Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Passive Immunizing Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Passive Immunizing Drugs by Application
  1. 5.1 Passive Immunizing Drugs Market by Application
  2. 5.1.1 Category II Exposure
  3. 5.1.2 Category III Exposure
  4. 5.2 Global Passive Immunizing Drugs Market Size by Application
  5. 5.2.1 Global Passive Immunizing Drugs Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Passive Immunizing Drugs Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Passive Immunizing Drugs Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Passive Immunizing Drugs Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Passive Immunizing Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Passive Immunizing Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Passive Immunizing Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Passive Immunizing Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Xingmeng Biopharmaceuticals (Suzhou)
  2. 6.1.1 Xingmeng Biopharmaceuticals (Suzhou) Company Information
  3. 6.1.2 Xingmeng Biopharmaceuticals (Suzhou) Business Overview
  4. 6.1.3 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Xingmeng Biopharmaceuticals (Suzhou) Passive Immunizing Drugs Product Portfolio
  6. 6.1.5 Xingmeng Biopharmaceuticals (Suzhou) Recent Developments
  7. 6.2 Wuhan Institute of Biological Products
  8. 6.2.1 Wuhan Institute of Biological Products Company Information
  9. 6.2.2 Wuhan Institute of Biological Products Business Overview
  10. 6.2.3 Wuhan Institute of Biological Products Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Wuhan Institute of Biological Products Passive Immunizing Drugs Product Portfolio
  12. 6.2.5 Wuhan Institute of Biological Products Recent Developments
  13. 6.3 Sichuan Yuanda Shuyang Pharmaceutical
  14. 6.3.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
  15. 6.3.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
  16. 6.3.3 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sichuan Yuanda Shuyang Pharmaceutical Passive Immunizing Drugs Product Portfolio
  18. 6.3.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
  19. 6.4 Shanxi Kangbao Biological Product
  20. 6.4.1 Shanxi Kangbao Biological Product Company Information
  21. 6.4.2 Shanxi Kangbao Biological Product Business Overview
  22. 6.4.3 Shanxi Kangbao Biological Product Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanxi Kangbao Biological Product Passive Immunizing Drugs Product Portfolio
  24. 6.4.5 Shanxi Kangbao Biological Product Recent Developments
  25. 6.5 Sharon Bio-Medicine
  26. 6.5.1 Sharon Bio-Medicine Company Information
  27. 6.5.2 Sharon Bio-Medicine Business Overview
  28. 6.5.3 Sharon Bio-Medicine Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sharon Bio-Medicine Passive Immunizing Drugs Product Portfolio
  30. 6.5.5 Sharon Bio-Medicine Recent Developments
  31. 6.6 Hualan Biological Engineering
  32. 6.6.1 Hualan Biological Engineering Company Information
  33. 6.6.2 Hualan Biological Engineering Business Overview
  34. 6.6.3 Hualan Biological Engineering Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hualan Biological Engineering Passive Immunizing Drugs Product Portfolio
  36. 6.6.5 Hualan Biological Engineering Recent Developments
  37. 6.7 North China Pharmaceutical
  38. 6.7.1 North China Pharmaceutical Company Information
  39. 6.7.2 North China Pharmaceutical Business Overview
  40. 6.7.3 North China Pharmaceutical Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 North China Pharmaceutical Passive Immunizing Drugs Product Portfolio
  42. 6.7.5 North China Pharmaceutical Recent Developments
  43. 6.8 Sinopharm Group
  44. 6.8.1 Sinopharm Group Company Information
  45. 6.8.2 Sinopharm Group Business Overview
  46. 6.8.3 Sinopharm Group Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sinopharm Group Passive Immunizing Drugs Product Portfolio
  48. 6.8.5 Sinopharm Group Recent Developments
  49. 6.9 Zydus Lifesciences
  50. 6.9.1 Zydus Lifesciences Company Information
  51. 6.9.2 Zydus Lifesciences Business Overview
  52. 6.9.3 Zydus Lifesciences Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zydus Lifesciences Passive Immunizing Drugs Product Portfolio
  54. 6.9.5 Zydus Lifesciences Recent Developments
  55. 6.10 Serum Institute of India
  56. 6.10.1 Serum Institute of India Company Information
  57. 6.10.2 Serum Institute of India Business Overview
  58. 6.10.3 Serum Institute of India Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Serum Institute of India Passive Immunizing Drugs Product Portfolio
  60. 6.10.5 Serum Institute of India Recent Developments
  61. 6.11 Sanofi Pasteur
  62. 6.11.1 Sanofi Pasteur Company Information
  63. 6.11.2 Sanofi Pasteur Business Overview
  64. 6.11.3 Sanofi Pasteur Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sanofi Pasteur Passive Immunizing Drugs Product Portfolio
  66. 6.11.5 Sanofi Pasteur Recent Developments
  67. 6.12 Kedrion Biopharma
  68. 6.12.1 Kedrion Biopharma Company Information
  69. 6.12.2 Kedrion Biopharma Business Overview
  70. 6.12.3 Kedrion Biopharma Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kedrion Biopharma Passive Immunizing Drugs Product Portfolio
  72. 6.12.5 Kedrion Biopharma Recent Developments
  73. 6.13 Kamada
  74. 6.13.1 Kamada Company Information
  75. 6.13.2 Kamada Business Overview
  76. 6.13.3 Kamada Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Kamada Passive Immunizing Drugs Product Portfolio
  78. 6.13.5 Kamada Recent Developments
  79. 6.14 Haffkine Bio-Pharmaceutical
  80. 6.14.1 Haffkine Bio-Pharmaceutical Company Information
  81. 6.14.2 Haffkine Bio-Pharmaceutical Business Overview
  82. 6.14.3 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Haffkine Bio-Pharmaceutical Passive Immunizing Drugs Product Portfolio
  84. 6.14.5 Haffkine Bio-Pharmaceutical Recent Developments
  85. 6.15 Grifols
  86. 6.15.1 Grifols Company Information
  87. 6.15.2 Grifols Business Overview
  88. 6.15.3 Grifols Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Grifols Passive Immunizing Drugs Product Portfolio
  90. 6.15.5 Grifols Recent Developments
  91. 6.16 Bharat Biotech
  92. 6.16.1 Bharat Biotech Company Information
  93. 6.16.2 Bharat Biotech Business Overview
  94. 6.16.3 Bharat Biotech Passive Immunizing Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Bharat Biotech Passive Immunizing Drugs Product Portfolio
  96. 6.16.5 Bharat Biotech Recent Developments
7 North America by Country
  1. 7.1 North America Passive Immunizing Drugs Sales by Country
  2. 7.1.1 North America Passive Immunizing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Passive Immunizing Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Passive Immunizing Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Passive Immunizing Drugs Market Size by Country
  6. 7.2.1 North America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Passive Immunizing Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Passive Immunizing Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Passive Immunizing Drugs Sales by Country
  2. 8.1.1 Europe Passive Immunizing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Passive Immunizing Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Passive Immunizing Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Passive Immunizing Drugs Market Size by Country
  6. 8.2.1 Europe Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Passive Immunizing Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Passive Immunizing Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Passive Immunizing Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Passive Immunizing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Passive Immunizing Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Passive Immunizing Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Passive Immunizing Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Passive Immunizing Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Passive Immunizing Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Passive Immunizing Drugs Sales by Country
  2. 10.1.1 South America Passive Immunizing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Passive Immunizing Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Passive Immunizing Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Passive Immunizing Drugs Market Size by Country
  6. 10.2.1 South America Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Passive Immunizing Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Passive Immunizing Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Passive Immunizing Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Passive Immunizing Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Passive Immunizing Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Passive Immunizing Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Passive Immunizing Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Passive Immunizing Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Passive Immunizing Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Passive Immunizing Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Passive Immunizing Drugs Value Chain Analysis
  2. 12.1.1 Passive Immunizing Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Passive Immunizing Drugs Production Mode & Process
  7. 12.2 Passive Immunizing Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Passive Immunizing Drugs Distributors
  10. 12.2.3 Passive Immunizing Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst